Butterfly Medical

Israel
Yoqne‘am ‘Illit, Northern District, Israel, 20692

Company profile

Butterfly Medical company profile

Butterfly Medical is a medical-device start-up that aims to improve the standard of care for men suffering from Benign Prostate Hyperplasia (BPH) or enlarged prostate. The company has developed a fast, simple and minimally invasive alternative treatment to first-line BPH medication and surgery. Butterfly Medical’s patented device can be placed in under 10 minutes, in-office, under local anesthesia, without surgical incision, heating or prostate tissue removal. The device aims to be the only in-office BPH treatment that delivers a long-term, effective solution with minimal side effects, requiring no hospitalization or general anesthesia. Early results from clinical trials are very promising with blocked urethras successfully opened and patients suffering no side effects. Further clinical studies are starting in leading medical centers in Europe. Visit www.butterfly-medical.com for more information.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2014-01-01, Year

Headquarters

Postal code
20692
Country code
IL
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
5
Total equity funding
$9M
Last funding
Non Equity Assistance / 2024-05-29
Last equity funding
Series B / $7M
Investors
8
Lead investors
2
Founders
2
Articles
34

Founders and investors

Founders

Dr. Adrian PazYehuda Bachar

Lead investors

MedTech InnovatorNew Rhein

Investors

Alon Medtech VenturesMassChallengeMedTech InnovatorMori ArkinNew Rhein